<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The article presents the results of investigation into hypothalamic-hypophyseal-adrenal system in cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> leading to <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>A hypothesis was put forward assuming a major role of luliberins in the pathogenesis of these disorders </plain></SENT>
<SENT sid="2" pm="."><plain>Reported are the data on practical application of luliberin in the therapy of <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental disorders</z:e> in cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical observations and inferences were confirmed in biochemical studies </plain></SENT>
</text></document>